Losartan Cost in Alaska 2026: Cash Price, Medicaid, Insurance and Discount Options

What Is Losartan and Why Do Alaskans Use It?

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for hypertension, heart failure with reduced ejection fraction, and diabetic nephropathy in patients with type 2 diabetes and elevated creatinine [1]. The drug blocks the AT1 receptor, lowering peripheral vascular resistance and reducing the kidney-damaging effects of angiotensin II. One tablet once daily is the standard regimen, with doses ranging from 25 mg to 100 mg depending on indication and tolerability.

Alaska has a disproportionately high burden of cardiovascular risk factors. The CDC reports that approximately 31% of Alaskan adults have been diagnosed with hypertension, and the state's rural geography means many patients travel hours to reach a clinic [2]. That access challenge makes affordable, once-daily oral therapy especially valuable, and losartan's generic availability since 2010 has brought its cost within reach for most patients.

The LIFE trial (Losartan Intervention For Endpoint Reduction in Hypertension, N=9,193) published in The Lancet in 2002 showed that losartan-based therapy reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% compared to atenolol-based therapy (P<0.001), with a particularly striking 25% relative risk reduction in fatal and nonfatal stroke [3]. That trial remains the foundational evidence supporting losartan as a first-line ARB for high-risk hypertensive patients.

How Much Does Losartan Cost in Alaska in 2026?

The average cash-pay price for generic losartan at Alaska retail pharmacies in 2026 is approximately $10 per month for a 30-tablet supply of the 50 mg dose. That number varies by chain, independent pharmacy, and geographic location within the state.

Merck's brand-name version, Cozaar, carries a manufacturer list price of approximately $80 per month. Very few patients pay that figure out of pocket; most insurers substitute generic losartan automatically. Still, uninsured Alaskans who ask for Cozaar by name at the pharmacy counter could face that higher charge unless they specifically request generic substitution.

Several factors shift the actual price a patient pays:

Pharmacy type. Large national chains (Walgreens, CVS, Walmart) and grocery-store pharmacies often have different pricing tiers. Walmart's $4/$10 generic program, where available in Alaska locations, may price a 30-day losartan supply at $4 and a 90-day supply at $10.

Discount card applied. GoodRx, RxSaver, and similar services negotiate rates with pharmacy benefit managers and regularly bring generic losartan below $10 per month at Alaska pharmacies. Checking the GoodRx price at your specific zip code before filling is a reliable way to find the lowest local rate.

Dose strength. The 25 mg tablet is sometimes priced differently from 50 mg and 100 mg tablets. Patients on higher doses may save money by requesting a double-strength tablet and splitting it, though this should only be done with prescriber approval.

Mail-order supply. A 90-day supply through a mail-order pharmacy often costs less per tablet than monthly retail fills. For Alaskans in remote communities, mail-order also eliminates travel.

Does Alaska Medicaid Cover Losartan?

Alaska Medicaid does not currently list losartan on its preferred drug list (PDL) for outpatient pharmacy benefits. This is a notable gap because ARBs are guideline-recommended first-line agents for hypertension with comorbid diabetes or chronic kidney disease, per the 2023 American College of Cardiology / American Heart Association Blood Pressure Guideline [4].

Patients enrolled in Alaska Medicaid who need losartan have two practical paths. First, a prescriber can submit a prior authorization (PA) request documenting medical necessity, particularly if ACE inhibitors are contraindicated due to cough or angioedema. Alaska Medicaid's PA process typically requires documentation that at least one PDL-preferred alternative was tried or is contraindicated. Second, cash-pay generic losartan at roughly $10 per month is inexpensive enough that some Medicaid patients find it cheaper and faster to pay out of pocket with a discount card rather than manage the PA process.

The Alaska Division of Health Care Services publishes its PDL updates quarterly. Prescribers and patients should check the current PDL at dhss.alaska.gov before assuming coverage status has not changed, as ARBs periodically move on and off preferred lists as generic pricing shifts.

Is Compounded Losartan Legal in Alaska?

Compounded losartan prepared by a 503A pharmacy is legal in Alaska. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a licensed compounding pharmacy may prepare losartan in non-commercially available strengths or forms when a prescriber provides a valid patient-specific prescription [5]. Alaska has its own state pharmacy board regulations that overlay federal 503A requirements, and any compounding pharmacy operating in Alaska must hold a current Alaska Pharmacy License issued by the Alaska Board of Pharmacy.

Why would a patient want compounded losartan when the commercial generic tablet costs roughly $10 per month? Three scenarios come up in clinical practice:

Oral suspension for pediatric or dysphagia patients. Losartan is approved for pediatric hypertension in patients 6 years and older, but commercial suspensions are not consistently available. A 503A pharmacy can compound a stable oral suspension at a patient-specific concentration. The FDA notes that pharmacists can prepare a 2.5 mg/mL suspension from commercially available losartan tablets using Ora-Plus and Ora-Sweet, which remains stable for 4 weeks refrigerated [1].

Combination preparations. Some prescribers and patients prefer a single capsule containing losartan plus a complementary agent, such as spironolactone, to reduce pill burden. Compounding allows this; commercial fixed-dose combinations do not always cover every clinically needed ratio.

Cost consideration in specific programs. Certain telehealth platforms and compounding pharmacies work together to offer losartan at reduced or zero cost as part of bundled treatment programs. The $0 per month figure cited in some Alaska-specific pharmacy data reflects these program arrangements, not a general market price.

Patients considering compounded losartan should confirm that the pharmacy holds PCAB (Pharmacy Compounding Accreditation Board) accreditation, which indicates it meets quality and testing standards beyond the minimum legal requirement.

Telehealth Prescribing of Losartan in Alaska

Telehealth prescribing of losartan is legal in Alaska, and the state has maintained permissive telehealth policies since expanding access during the COVID-19 public health emergency. Alaska statute AS 08.64.364 and corresponding regulations allow a licensed Alaska provider to establish a patient-provider relationship via synchronous audio-video technology and prescribe Schedule V and non-controlled medications, including losartan [6].

For a hypertensive patient in Fairbanks, Juneau, or a rural community without ready clinic access, a telehealth visit covers the clinical workup: blood pressure history, medication reconciliation, kidney function review, and prescription generation. The prescriber sends the electronic prescription to the patient's preferred pharmacy, or to a mail-order pharmacy if the patient requests.

HealthRX clinicians who prescribe losartan via telehealth in Alaska follow a standard intake that includes review of a recent basic metabolic panel (potassium and creatinine are particularly relevant given losartan's mechanism), current medication list for drug interactions, and a documented blood pressure reading from a home device or recent in-person measurement.

The HealthRX Alaska Losartan Intake Framework used by our clinical team includes four checkpoints before initiating therapy remotely: (1) confirmed eGFR above 30 mL/min/1.73 m2 or nephrology co-management in place, (2) baseline serum potassium <5.0 mEq/L, (3) no concurrent use of aliskiren in diabetic patients per the FDA's 2012 contraindication update [1], and (4) patient-supplied home blood pressure log with at least five readings taken on separate days. Patients who clear all four checkpoints proceed to a 30-day starter prescription; those who do not are referred for in-person evaluation.

Insurance Coverage for Losartan in Alaska

Most commercial insurance plans available on the Alaska Health Insurance Exchange (AK SHOP and individual market plans) cover generic losartan at Tier 1 or Tier 2. Tier 1 generic copays on Exchange plans typically range from $0 to $15 per 30-day fill, making losartan one of the lowest out-of-pocket prescriptions in the cardiovascular drug class.

Medicare Part D plans available in Alaska vary by formulary. The 2024 Medicare Part D Low-Income Subsidy (LIS), sometimes called Extra Help, caps copays for Tier 1 generics at $4.50 per fill for full-subsidy beneficiaries [7]. Losartan appears on the formulary of every major Part D plan active in Alaska for plan year 2026, though the tier assignment and resulting copay differ by plan. Beneficiaries can use the Medicare Plan Finder at medicare.gov to compare out-of-pocket costs across specific plans.

Employer-sponsored plans operating in Alaska, whether self-insured or fully insured, almost universally cover generic losartan given its position on the WHO Model List of Essential Medicines and its cost-effectiveness profile. A 2020 analysis published in Hypertension found that losartan and other generic ARBs generate approximately $1 to 200 in downstream cardiovascular event cost savings per patient per year compared to no treatment [8]. That figure makes any employer plan's case for Tier 1 placement fairly straightforward.

For patients whose plans do not cover losartan or who face a short coverage gap, the next section outlines savings alternatives.

The Cheapest Ways to Get Losartan in Alaska

Paying $10 per month cash is already affordable for many patients, but several additional mechanisms can bring costs lower or to zero.

GoodRx and discount card programs. GoodRx, RxSaver, and Blink Health negotiate pricing with participating pharmacies. In Anchorage, GoodRx prices for generic losartan 50 mg (30 tablets) have been quoted below $5 at certain pharmacy chains. These cards are free to obtain and do not require insurance enrollment. Patients cannot use them simultaneously with insurance, but for uninsured patients or those in the Medicare coverage gap, they are the fastest savings option.

NeedyMeds. NeedyMeds.org maintains a database of patient assistance programs. Merck historically has offered a patient assistance program for Cozaar for uninsured patients meeting income thresholds, though program availability changes annually. For generic losartan, NeedyMeds lists several pharmacy discount programs applicable in Alaska.

340B Drug Pricing Program. Federally Qualified Health Centers (FQHCs) and other 340B-eligible entities in Alaska can purchase losartan at the 340B ceiling price, which is substantially below the wholesale acquisition cost. Patients who receive care at an FQHC, such as Southcentral Foundation in Anchorage or Norton Sound Health Corporation in Nome, may access losartan at reduced or zero cost through the 340B program. The Health Resources and Services Administration (HRSA) maintains the list of 340B-covered entities [9].

90-day mail-order fills. Most Part D and commercial plans price a 90-day mail-order supply at two months' copay rather than three. For a $10-per-month cash-pay patient, ordering a 90-day supply from a mail-order pharmacy that participates in discount card programs can bring the effective monthly cost to roughly $3 to $5.

Alaska Native Tribal Health System. Alaska Native and American Indian patients who receive care through the Alaska Native Tribal Health Consortium (ANTHC) or a tribal health organization may receive losartan at no cost through Indian Health Service (IHS) pharmacy benefits, which are federally funded and separate from Medicaid [10].

Losartan Dose, Safety, and Monitoring in Alaska Patients

Standard losartan dosing for hypertension begins at 50 mg once daily, with titration to 100 mg once daily if blood pressure remains uncontrolled at 4 weeks. For diabetic nephropathy, the approved target dose is 100 mg once daily, a regimen supported by the RENAAL trial (N=1,513), which showed a 16% reduction in the composite endpoint of doubling of serum creatinine, end-stage renal disease, or death (P=0.02) [11].

Common side effects include dizziness, hyperkalemia, and a small increase in serum creatinine at initiation. Losartan does not cause the dry cough associated with ACE inhibitors, which is one reason clinicians prefer ARBs in patients who have experienced ACE-inhibitor-induced cough.

The American Heart Association's 2023 guideline on hypertension states: "ARBs are recommended as preferred agents in patients with hypertension and chronic kidney disease, particularly those with diabetes, given their kidney-protective effects beyond blood pressure lowering" [4].

Monitoring recommendations after starting losartan include a basic metabolic panel at 2 to 4 weeks to check potassium and creatinine, then every 6 to 12 months in stable patients with normal baseline values. Patients with baseline eGFR <45 mL/min/1.73 m2 warrant more frequent monitoring, typically every 3 months. In Alaska's rural communities, point-of-care testing at community health aide clinics can substitute for laboratory draws when transportation to a lab is not feasible.

Losartan is absolutely contraindicated in pregnancy. The FDA Pregnancy Category label (now the PLLR system) describes fetal renal dysgenesis, oligohydramnios, and neonatal death with second- and third-trimester ARB exposure [1]. Women of childbearing age prescribed losartan in Alaska should receive counseling about contraception and be switched to a safer agent if pregnancy is planned or confirmed.

Losartan vs. Other ARBs on Cost in Alaska

Losartan is not the only ARB available generically in Alaska. Valsartan, irbesartan, and olmesartan are all available as generics, with broadly similar retail pricing. The choice among ARBs for most uncomplicated hypertension is largely driven by formulary placement and cost. Losartan's longer generic history (generics entered the market in 2010) and wider manufacturing base make it the most consistently priced option.

One pharmacokinetic distinction matters clinically: losartan has an active metabolite (E-3174) that is 10 to 40 times more potent than the parent compound at the AT1 receptor. This two-compartment activity profile may contribute to its 24-hour blood pressure lowering effect at once-daily dosing [12]. Telmisartan, by contrast, has a longer half-life and some studies suggest superior 24-hour coverage, but its generic price in Alaska can run $5 to $15 higher per month than losartan, depending on pharmacy and discount card.

For patients with a specific indication of diabetic nephropathy, losartan and irbesartan are the two ARBs with the strongest direct trial evidence (RENAAL and IDNT respectively), making them guideline-preferred over other ARBs in that indication [4].